Cargando…
INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden AB
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963414/ https://www.ncbi.nlm.nih.gov/pubmed/35174869 http://dx.doi.org/10.2340/jrm.v54.2027 |
_version_ | 1784677985594376192 |
---|---|
author | KOCICA, Jan KOLCAVA, Jan SLADECKOVA, Michaela STOURAC, Pavel VLCKOVA, Eva DOSBABA, Filip KRATOCHVILOVA, Jitka BEDNARIK, Josef |
author_facet | KOCICA, Jan KOLCAVA, Jan SLADECKOVA, Michaela STOURAC, Pavel VLCKOVA, Eva DOSBABA, Filip KRATOCHVILOVA, Jitka BEDNARIK, Josef |
author_sort | KOCICA, Jan |
collection | PubMed |
description | OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression. |
format | Online Article Text |
id | pubmed-8963414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Medical Journals Sweden AB |
record_format | MEDLINE/PubMed |
spelling | pubmed-89634142022-03-31 INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS KOCICA, Jan KOLCAVA, Jan SLADECKOVA, Michaela STOURAC, Pavel VLCKOVA, Eva DOSBABA, Filip KRATOCHVILOVA, Jitka BEDNARIK, Josef J Rehabil Med Original Report OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression. Medical Journals Sweden AB 2022-03-29 /pmc/articles/PMC8963414/ /pubmed/35174869 http://dx.doi.org/10.2340/jrm.v54.2027 Text en © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Original Report KOCICA, Jan KOLCAVA, Jan SLADECKOVA, Michaela STOURAC, Pavel VLCKOVA, Eva DOSBABA, Filip KRATOCHVILOVA, Jitka BEDNARIK, Josef INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title | INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title_full | INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title_fullStr | INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title_full_unstemmed | INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title_short | INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS |
title_sort | intensive circuit class therapy in patients with relapsing-remitting multiple sclerosis |
topic | Original Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963414/ https://www.ncbi.nlm.nih.gov/pubmed/35174869 http://dx.doi.org/10.2340/jrm.v54.2027 |
work_keys_str_mv | AT kocicajan intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT kolcavajan intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT sladeckovamichaela intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT stouracpavel intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT vlckovaeva intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT dosbabafilip intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT kratochvilovajitka intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis AT bednarikjosef intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis |